Trade Summary

1 week ago, Magrath George, serving as CEO at Opus Genetics, Inc. (IRD), sold 24,438 shares at $5.21 per share, for a total transaction value of $127,327.00. Following this transaction, Magrath George now holds 1,750,855 shares of IRD.

This sale represents a 1.00% decrease in Magrath George's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 2 days after the trade was made.

Opus Genetics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.